Dermira Inc.

(DERM) Trade

By |

Profile

Dermira Inc is a biopharmaceutical company focuses on the development and commercialization of medical dermatology products to dermatologists and their patients primarily in the United States.The company's late-stage product candidates include Cimzia, an injectable biologic tumor necrosis factor-alpha inhibitor to treat various inflammatory diseases, as well as to treat patients with moderate-to-severe chronic plaque psoriasis; Glycopyrronium tosylate, a small-molecule anticholinergic product that is in Phase III clinical trial for the treatment of primary axillary hyperhidrosis or excessive underarm sweating; and Olumacostat glasaretil, a small-molecule sebum inhibitor, which is in Phase III clinical trial to treat acne vulgaris or acne.

Contact Information

Website: www.dermira.com
Email: Investor@dermira.com
Main Phone: +1 650 421-7200
Address: 275 Middlefield Road
Address 2: Suite 150
State: CA
City / Town: Menlo Park
Country: USA
Postal Code: 94025

Issuer Information

Exchange: NGS
CEO: Thomas G. Wiggans
Employees: 162
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 10.83 $ -0.06 (-0.55%)
Last Price 10.83 Change $ -0.06 Change % -0.55 Tick N/A
Bid 1.00 Bid Size 200.00 Ask 10.90 Ask Size 200.00
Open 10.88 High 10.97 Low 10.47 Prev Close 10.89
Last Trade Volume 435,499 52 Wk Hi 31.42 52 Wk Low 6.98
Market Cap 456.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 42,120,870.00 EPS (TTM) -4.90 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 61
Number of Buys 1 26
Number of Sells 0 35
Net Activity 10000 33340
Last 10 Buys Shares
Frederick B. Craves 1,000
Frederick B. Craves 1,000
Matthew K. Fust 1,000
Last 10 Sell Shares
Eugene A. Bauer 1,000
Eugene A. Bauer 1,000
David Eric Cohen 1,000
Eugene A. Bauer 1,000
David Eric Cohen 1,000
Eugene A. Bauer 1,000
Eugene A. Bauer 1,000
Christopher M. Griffith 1,000
Christopher M. Griffith 1,000
David Eric Cohen 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 48 48 48 48
Low Target Price Estimate 9 9 9 9
Mean Target Price Estimate 27.71 27.71 27.72 27.71
Standard Deviation 13.8 13.8 13.8 13.8
Date of Most Recent Estimate 05/29/18 05/29/18 05/22/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 1 1
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.13 2.13 2.13 2.13